MicroRNA-140 is not involved in sepsis-induced muscle atrophy

Jaehoon Shin1, Shigeru Miyaki2, Hiroshi Asahara3

  • 1Laboratory of Muscle Biology, Faculty of Sport Sciences, Waseda University, Saitama, Japan.

Insights

MicroRNA-140 (miR-140) does not influence lipopolysaccharide (LPS)-induced skeletal muscle atrophy. Deleting miR-140 in mice did not alter muscle wasting or proteolysis markers following LPS exposure.

Area of Science:

  • Biochemistry
  • Physiology
  • Molecular Biology

Background:

  • Sepsis triggers a severe inflammatory response, often leading to skeletal muscle atrophy.
  • Previous research suggested microRNA-140 (miR-140) plays a role in mitigating lipopolysaccharide (LPS)-induced muscle wasting.

Purpose of the Study:

  • To investigate the role of miR-140 in LPS-induced skeletal muscle atrophy using a genetic knockout model.
  • To analyze the impact of miR-140 deletion on both slow-twitch and fast-twitch muscle groups.

Main Methods:

  • Utilized miR-140 knockout (-/-) mice and wild-type (WT) littermates.
  • Administered a single dose of lipopolysaccharide (LPS) to induce sepsis-like conditions.
  • Assessed muscle weight, fiber cross-sectional area, and expression of key proteolysis markers (MuRF1, MAFbx/atrogin-1).

Main Results:

  • LPS injection induced significant muscle atrophy in both WT and miR-140-/- mice.
  • No significant differences in muscle atrophy or proteolysis marker expression were observed between genotypes.
  • Ubiquitinated protein levels were comparable between WT and miR-140-/- mice after LPS administration.

Conclusions:

  • The absence of miR-140 does not exacerbate or protect against LPS-induced skeletal muscle atrophy.
  • miR-140 is not a critical factor in the development of muscle wasting following LPS exposure in this model.
  • This study provides novel insights into slow-twitch muscle responses in LPS-induced muscle wasting concerning miR-140 manipulation.